Health Care & Life Sciences » Pharmaceuticals | Swedish Orphan Biovitrum AB

Swedish Orphan Biovitrum AB

Swedish Orphan Biovitrum AB ADR
Stock Exchange Other OTC
EPS
$0.83
Market Cap
$7.76 B
Shares Outstanding
273.32 M
Public Float
-
Swedish Orphan Biovitrum AB
Stock Exchange OTC Publication Venue
EPS
SEK10.15
Market Cap
SEK55.1 B
Shares Outstanding
297.52 M
Public Float
162.03 M

Profile

Address
Tomtebodavägen 23A
Solna AB 112 76
Sweden
Employees -
Website http://www.sobi.com
Updated 07/08/2019
Swedish Orphan Biovitrum AB engages as a biopharmaceutical company. It provides therapies and services for patients with rare diseases. The firm's core products include Kineret within the inflammation therapeutic area; and Orfadin, Ammonaps, and Ammonul within the genetics and metabolic therapeutic area.

Financials

View All

Lena Elisabeth Svanberg
Director
David Allsopp
Director